search
Back to results

The POWER BARIATRIC Trial: Physical Outcomes With Exercise Regimens on BARIATRIC Patients (POWER)

Primary Purpose

Obesity, Muscle Loss, Adiposity

Status
Recruiting
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
Physical activity training
Sponsored by
Tel Aviv University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Obesity focused on measuring Obesity, Bariatric Surgery, Muscle mass loss, exercise training

Eligibility Criteria

20 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Sedentary participants: regular exercise performed <1 hour per week
  • Candidates for primary bariatric surgery at Herzliya Medical Center in accordance to the National Institutes of Health (NIH) criteria for surgery: (body mass index (BMI) > 40 without coexisting co-morbidities or BMI > 35 with > 1 severe obesity-related comorbidities)
  • Sex: all
  • Age: 20 to 65 years.

Exclusion Criteria:

  • Severe cardiopulmonary disease (e.g., recent myocardial infarction or unstable angina)
  • Musculoskeletal or neuromuscular impairments that preclude exercise training
  • Cognitive impairments
  • Use of drugs that affect bone or muscle metabolism (mainly steroids)
  • Patients with previous bariatric surgery

Sites / Locations

  • Tel Aviv UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

No Intervention

Arm Label

Aerobic exercise training

Resistance exercise training

Combination exercise training

The control group

Arm Description

The aerobic exercise training group, weeks 5-8 after surgery: this training will consist of 30 min. of walking, 3 times per week at an intensity of 60-70% of peak VO2 or RPE 6-7 on the Borg scale. Weeks 9-26 after surgery: this training will consist of 60 minutes of exercise, 3 times per week at an intensity of 65-80% of peak VO2 or RPE 6-8 on the Borg scale. The aerobic exercises will consist of a treadmill or outside walking or running, stationary cycling or elliptical trainer in continuous and interval training.

Resistance exercise training group, weeks 5-8 after surgery: this training will consist of 5-10 minutes of warmup, followed by 6-8 multi-joint exercises for major muscle groups, comprising 2 sets of 10 to 25 repetitions at 40% of the one-repetition maximum (1-RM) for each exercise. The intensity will increase on weeks 9-26 after surgery to 8-10 multi-joint exercises of 3-4 sets of 10 to 25 repetitions. For this training participants will use free-weights and body weight exercises.

The combination exercise training will consist of a combined aerobic and resistance exercise training sessions three times weekly. At weeks 5-8 after surgery the sessions will include 5-10 minutes of warmup, followed by 3-4 multi-joint exercises for major muscle groups, comprising 2 sets of 10 to 25 repetitions at 40% of the one-repetition maximum (1-RM) for each exercise. Afterwards the aerobic part of the training will consist of 10-15 minutes of aerobic exercises (treadmill or outside walking or running, stationary cycling or outdoors or elliptical trainer) at 60-70% of peak VO2 or RPE 6-7 at Borg scale. The intensity will increase on weeks 9-26 after surgery to 4-5 multi-joint exercises of 3-4 sets of 10 to 25 repetitions and 30 minutes of aerobic exercises at 65-80% of peak VO2 or RPE 6-8 at Borg scale.

The control group will receive routine health care without exercise supervision (clinical and nutritional follow up).

Outcomes

Primary Outcome Measures

Muscle mass (cm3)
Changes in thigh muscles volume
Body composition - fat mass
Fat mass (Kg)
Body composition
Fat free mass (Kg)

Secondary Outcome Measures

Microbial composition and changes
16S rRNA profiling
Blood measurements - cardiometabolic markers
Cardiometabolic markers: Glucose (mg/dl), lipid profile (total cholesterol in mg/dl, HDL in mg/dl, LDL in mg/dl)
Blood measurements - Insulin
Insulin (pmol/L)
Blood measurements for skeletal muscle metabolism assessment
Levels of anabolic hormones such as growth hormone (ng/ml) (GH), insulin like growth factor (ng/ml) (IGF-1). Marker of inhibition of skeletal muscle growth: Myostatin (ng/ml)
Blood measurements - Inflammatory markers
Interleukin-6 (pg/ml) (IL6)
Blood measurements for nutritional status
Markers for nutritional status: Hemoglobin (g/dl), albumin (g/dl)
Blood measurements for micronutrients
Ferritin (ng/ml), B12 (ng/ml)
Blood measurements for liver function
Liver enzymes: alanine aminotransferase in units per liter (U/L) (AST), gamma-glutamyltransferase (U/L)(GGT), alanine aminotransferase (U/L) (ALT), alkaline phosphatase (U/L) (ALP);
Blood measurements of adipokines - leptin
Leptin (ng/ml)
Blood measurements of adipokines - adiponectin
Adiponectin (μg/ml)
Blood measurements for bone status
Blood bone markers such as Collagen Type-1 C-Telopeptide in μg/L (CTX) and total procollagen type 1 N-terminal propeptide in μg/L (P1NP).
Bone density changes
Assessed by DEXA scan (T score and g/cm^2)
Anthropometric measurements - BMI
Weight (kg) and height (m) will be combined to calculate BMI (kg/m^2)
waist circumference as part of Anthropometric measurements
waist circumference (cm)
Weight loss percentage outcomes
% Excess weight loss (%EWL) will be calculated by [(initial weight (kg))-(post operative weight(kg))] / [(initial weight in kg) - (ideal body weight in kg)]. Total weight loss % (TWL%) will be calculated by [(initial weight (kg))-(post operative weight(kg))] / initial weight (kg).

Full Information

First Posted
February 8, 2021
Last Updated
January 23, 2023
Sponsor
Tel Aviv University
Collaborators
Herzliya Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT04777305
Brief Title
The POWER BARIATRIC Trial: Physical Outcomes With Exercise Regimens on BARIATRIC Patients
Acronym
POWER
Official Title
The POWER BARIATRIC Trial: Physical Outcomes With Exercise Regimens on BARIATRIC Patients
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
August 1, 2021 (Actual)
Primary Completion Date
September 30, 2023 (Anticipated)
Study Completion Date
October 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Tel Aviv University
Collaborators
Herzliya Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study aims to determine how different types of exercise regimens (resistance, aerobic, or combined exercise regimens) can be used to minimize muscle loss and mobilize body fat in severely obese patients after bariatric surgery (BS), despite the rapid surgery-induced weight loss. Additionally, the study will examine how changes in the intestinal microbiota following BS act as a mediation factor that alter tissue-specific responses in muscle and adipose tissue. The study will also evaluate the effect of different types of exercise regimens on cardiometabolic markers, endocrine response, and physical function following BS. Sixty sedentary (regular exercise <1 hour per week) candidates to bariatric surgery at Herzliya Medical Center will be recruited to participate in this six-month-long randomized control study. Participants will be randomly assigned to either one of three exercise regimens intervention groups (aerobic, resistance, or a combined exercise regimen combining aerobic and resistance exercises) or a control group that will receive standard care. Training will be supervised and matched for metabolic equivalent (METs). The intervention will take place at the Sylvan Adams Sports Institute at Tel Aviv University and an online platform. All measurements will be taken at a presurgical baseline assessment and throughout the study, and will include changes of muscle mass and adipose tissue distribution, measured by a 3-Tesla magnetic resonance imaging (MRI); body composition- will be assessed using multichannel bioelectrical impedance (Seca); Bone mass, will be measured by a Dual-energy X-ray absorptiometry (DEXA); microbiota composition and changes will be evaluated by stool samples that will be subjected to 16S ribosomal ribonucleic acid (16s rRNA) profiling and metagenomics analysis; fasting blood samples will be used to examine endocrine control and cardiometabolic markers; anthropometric measurements to assess surgery results associations with physical activity outcomes and physical function will be assessed by several validated performance assessments, including handgrip, six-minute walk, sit-to-stand, maximum voluntary contraction, and maximal oxygen consumption (VO2max).
Detailed Description
The primary aim will be to determine how different types of exercise regimens (resistance, aerobic, or combined exercise regimens) can be used to minimize muscle loss and mobilize body fat in severely obese patients after BS, despite the rapid surgery-induced weight loss. Secondary aims will include: I. To examine the effect of different exercise regimens on the composition and diversity of microbiomes, and their role in mediating muscle mass preservation following BS. II.Evaluate changes in cardiometabolic markers and endocrine response to different exercise regimens and evaluates microbiome mediation of these changes after BS. III.Assess the effect of different exercise regimens on physical function among patients following BS. IV.Clarify the mechanisms of muscle preservation and fat loss involving hormonal response and atrophy related-genes expression. After baseline measurements (detailed below), participants will be randomized into one of four groups: 1. control group (n=15) that includes routine health care; 2. aerobic exercise training group (n=15), 3. resistance exercise training group (n=15), 4. combined aerobic and resistance exercise training group (n=15). Training sessions will be both in-person and as online exercise supervision. All groups will be supported by a dietitian as part of the routine health care after the bariatric surgery. The dietetic program for all groups will consist of a balanced diet by diet progression guidelines for bariatric patients (XX,ZZ) and the bariatric food pyramid (55). The protein content will be a minimum of 60 gr/protein per day, according to current guidelines (XX,ZZ) . Each training session will increase gradually up to 60 minutes per session, three times a week. Participants will be randomized into 4 groups for 26 weeks of intervention including aerobic, resistance, combined exercise training (aerobic + resistance) and a control group without exercise training. All exercise training will be matched in metabolic equivalent (METs) and the time of training per week. Participants will begin a two weeks exercise adaptation period at 3-4 postoperative weeks. The activity adaptation plan will consist of 15-20 min. of walking, three times per week, at an intensity of 40-60% of peak oxygen consumption (VO2) or rate of perceived exertion (RPE) 4-6 on the Borg scale for all intervention groups. Following this period, each group will participate in a specific progressive training with the following regimen: Aerobic exercise training group, weeks 5-8 after surgery: this training will consist of 30 min. of walking, 3 times per week at an intensity of 60-70% of peak VO2 or RPE 6-7 on Borg scale. Weeks 9-26 after surgery: this training will consist of 60 minutes of exercise, 3 times per week at an intensity of 65-80% of peak VO2 or RPE 6-8 on the Borg scale. The aerobic exercises will consist of a treadmill or outside walking or running, stationary cycling or elliptical trainer in continuous and interval training. Resistance exercise training group, weeks 5-8 after surgery: this training will consist of 5-10 minutes of warmup, followed by 6-8 multi-joint exercises for major muscle groups, comprising 2 sets of 10 to 25 repetitions at 40% of the one-repetition maximum (1-RM) for each exercise. The intensity will increase on weeks 9-26 after surgery to 8-10 multi-joint exercises of 3-4 sets of 10 to 25 repetitions. For this training participants will use free-weights and bodyweight exercises. The combination exercise training will consist of a combined aerobic and resistance exercise training sessions three times weekly. At weeks 5-8 after surgery, the sessions will include 5-10 minutes of warmup, followed by 3-4 multi-joint exercises for major muscle groups, comprising 2 sets of 10 to 25 repetitions at 40% of the one-repetition maximum (1-RM) for each exercise. Afterward, the aerobic part of the training will consist of 10-15 minutes of aerobic exercises (treadmill or outside walking or running, stationary cycling or outdoors or elliptical trainer) at 60-70% of peak VO2 or RPE 6-7 at Borg scale. The intensity will increase on weeks 9-26 after surgery to 4-5 multi-joint exercises of 3-4 sets of 10 to 25 repetitions and 30 minutes of aerobic exercises at 65-80% of peak VO2 or RPE 6-8 at Borg scale. The control group will receive conventional treatment so as the other groups (medical and nutritional follow up). Statistical analysis plan...

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Muscle Loss, Adiposity
Keywords
Obesity, Bariatric Surgery, Muscle mass loss, exercise training

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Aerobic exercise training
Arm Type
Experimental
Arm Description
The aerobic exercise training group, weeks 5-8 after surgery: this training will consist of 30 min. of walking, 3 times per week at an intensity of 60-70% of peak VO2 or RPE 6-7 on the Borg scale. Weeks 9-26 after surgery: this training will consist of 60 minutes of exercise, 3 times per week at an intensity of 65-80% of peak VO2 or RPE 6-8 on the Borg scale. The aerobic exercises will consist of a treadmill or outside walking or running, stationary cycling or elliptical trainer in continuous and interval training.
Arm Title
Resistance exercise training
Arm Type
Experimental
Arm Description
Resistance exercise training group, weeks 5-8 after surgery: this training will consist of 5-10 minutes of warmup, followed by 6-8 multi-joint exercises for major muscle groups, comprising 2 sets of 10 to 25 repetitions at 40% of the one-repetition maximum (1-RM) for each exercise. The intensity will increase on weeks 9-26 after surgery to 8-10 multi-joint exercises of 3-4 sets of 10 to 25 repetitions. For this training participants will use free-weights and body weight exercises.
Arm Title
Combination exercise training
Arm Type
Experimental
Arm Description
The combination exercise training will consist of a combined aerobic and resistance exercise training sessions three times weekly. At weeks 5-8 after surgery the sessions will include 5-10 minutes of warmup, followed by 3-4 multi-joint exercises for major muscle groups, comprising 2 sets of 10 to 25 repetitions at 40% of the one-repetition maximum (1-RM) for each exercise. Afterwards the aerobic part of the training will consist of 10-15 minutes of aerobic exercises (treadmill or outside walking or running, stationary cycling or outdoors or elliptical trainer) at 60-70% of peak VO2 or RPE 6-7 at Borg scale. The intensity will increase on weeks 9-26 after surgery to 4-5 multi-joint exercises of 3-4 sets of 10 to 25 repetitions and 30 minutes of aerobic exercises at 65-80% of peak VO2 or RPE 6-8 at Borg scale.
Arm Title
The control group
Arm Type
No Intervention
Arm Description
The control group will receive routine health care without exercise supervision (clinical and nutritional follow up).
Intervention Type
Other
Intervention Name(s)
Physical activity training
Intervention Description
Participants will be randomized into either one of three intervention groups (aerobic training, resistance training, or combined training comprised of resistance and aerobic training) and a control group. Training is described in the arm description section.
Primary Outcome Measure Information:
Title
Muscle mass (cm3)
Description
Changes in thigh muscles volume
Time Frame
At baseline and after 26 weeks of intervention
Title
Body composition - fat mass
Description
Fat mass (Kg)
Time Frame
At baseline and after 13 and 26 weeks of intervention
Title
Body composition
Description
Fat free mass (Kg)
Time Frame
At baseline and after 13 and 26 weeks of intervention
Secondary Outcome Measure Information:
Title
Microbial composition and changes
Description
16S rRNA profiling
Time Frame
At baseline and after 13 and 26 weeks of intervention
Title
Blood measurements - cardiometabolic markers
Description
Cardiometabolic markers: Glucose (mg/dl), lipid profile (total cholesterol in mg/dl, HDL in mg/dl, LDL in mg/dl)
Time Frame
At baseline and after 13 and 26 weeks of intervention
Title
Blood measurements - Insulin
Description
Insulin (pmol/L)
Time Frame
At baseline and after 13 and 26 weeks of intervention
Title
Blood measurements for skeletal muscle metabolism assessment
Description
Levels of anabolic hormones such as growth hormone (ng/ml) (GH), insulin like growth factor (ng/ml) (IGF-1). Marker of inhibition of skeletal muscle growth: Myostatin (ng/ml)
Time Frame
At baseline and after 13 and 26 weeks of intervention
Title
Blood measurements - Inflammatory markers
Description
Interleukin-6 (pg/ml) (IL6)
Time Frame
At baseline and after 13 and 26 weeks of intervention
Title
Blood measurements for nutritional status
Description
Markers for nutritional status: Hemoglobin (g/dl), albumin (g/dl)
Time Frame
At baseline and after 13 and 26 weeks of intervention
Title
Blood measurements for micronutrients
Description
Ferritin (ng/ml), B12 (ng/ml)
Time Frame
At baseline and after 13 and 26 weeks of intervention
Title
Blood measurements for liver function
Description
Liver enzymes: alanine aminotransferase in units per liter (U/L) (AST), gamma-glutamyltransferase (U/L)(GGT), alanine aminotransferase (U/L) (ALT), alkaline phosphatase (U/L) (ALP);
Time Frame
At baseline and after 13 and 26 weeks of intervention
Title
Blood measurements of adipokines - leptin
Description
Leptin (ng/ml)
Time Frame
At baseline and after 13 and 26 weeks of intervention
Title
Blood measurements of adipokines - adiponectin
Description
Adiponectin (μg/ml)
Time Frame
At baseline and after 13 and 26 weeks of intervention
Title
Blood measurements for bone status
Description
Blood bone markers such as Collagen Type-1 C-Telopeptide in μg/L (CTX) and total procollagen type 1 N-terminal propeptide in μg/L (P1NP).
Time Frame
At baseline and after 13 and 26 weeks of intervention
Title
Bone density changes
Description
Assessed by DEXA scan (T score and g/cm^2)
Time Frame
At baseline and after 13 and 26 weeks of intervention
Title
Anthropometric measurements - BMI
Description
Weight (kg) and height (m) will be combined to calculate BMI (kg/m^2)
Time Frame
At baseline and after 13 and 26 weeks of intervention
Title
waist circumference as part of Anthropometric measurements
Description
waist circumference (cm)
Time Frame
At baseline and after 13 and 26 weeks of intervention
Title
Weight loss percentage outcomes
Description
% Excess weight loss (%EWL) will be calculated by [(initial weight (kg))-(post operative weight(kg))] / [(initial weight in kg) - (ideal body weight in kg)]. Total weight loss % (TWL%) will be calculated by [(initial weight (kg))-(post operative weight(kg))] / initial weight (kg).
Time Frame
At baseline and after 13 and 26 weeks of intervention
Other Pre-specified Outcome Measures:
Title
Quality of life (QoL)
Description
Will be assessed by the Bariatric Analysis and Reporting Outcome System (BAROS) questionnaire- measured by the results score
Time Frame
At baseline and after 13 and 26 weeks of intervention
Title
Physical function - 6 min walk test
Description
6 min walk test will be assessed in meters
Time Frame
At baseline and after 13 and 26 weeks of intervention
Title
Physical function - sit to stand test
Description
Sit to stand test will be assessed in seconds
Time Frame
At baseline and after 13 and 26 weeks of intervention
Title
Strength assessment
Description
Will be assessed by performance tests Handgrip test (kg), Estimated one-repetition maximum (the maximum weight a participant can lift, in one attempt, in the bench press and leg press in kg)
Time Frame
At baseline and after 13 and 26 weeks of intervention
Title
Strength assessment - maximum voluntary contraction
Description
Maximum voluntary contraction (in Newton)
Time Frame
At baseline and after 13 and 26 weeks of intervention
Title
Nutritional intake
Description
Will be assessed by validated questionnaires such as food diary. Macronutrients composition will be measured from the self-reported nutritional intake: kcal daily intake, protein intake (in gr and in %of total kcal), carbohydrate intake (in gr and in %of total kcal) and fat intake (in gr and in %of total kcal).
Time Frame
At baseline and after 13 and 26 weeks of intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Sedentary participants: regular exercise performed <1 hour per week Candidates for primary bariatric surgery at Herzliya Medical Center in accordance to the National Institutes of Health (NIH) criteria for surgery: (body mass index (BMI) > 40 without coexisting co-morbidities or BMI > 35 with > 1 severe obesity-related comorbidities) Sex: all Age: 20 to 65 years. Exclusion Criteria: Severe cardiopulmonary disease (e.g., recent myocardial infarction or unstable angina) Musculoskeletal or neuromuscular impairments that preclude exercise training Cognitive impairments Use of drugs that affect bone or muscle metabolism (mainly steroids) Patients with previous bariatric surgery
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yftach Gepner, Ph.D.
Phone
+972733804726
Email
gepner@tauex.tau.ac.il
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yftach Gepner, Ph.D.
Organizational Affiliation
Tel Aviv University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Tel Aviv University
City
Tel Aviv
State/Province
Other
ZIP/Postal Code
6997801
Country
Israel
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yftach Gepner

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

The POWER BARIATRIC Trial: Physical Outcomes With Exercise Regimens on BARIATRIC Patients

We'll reach out to this number within 24 hrs